Symposia: Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, adult, epidemiology, Lymphomas, Translational Research, elderly, Clinical Research, health outcomes research, T Cell lymphoma, Diseases, Therapies, Immunotherapy, real-world evidence, Adverse Events, Lymphoid Malignancies, young adult , Monoclonal Antibody Therapy, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, adult, epidemiology, Lymphomas, Translational Research, elderly, Clinical Research, health outcomes research, T Cell lymphoma, Diseases, Therapies, Immunotherapy, real-world evidence, Adverse Events, Lymphoid Malignancies, young adult , Monoclonal Antibody Therapy, Study Population, Human
Sunday, December 11, 2022: 4:30 PM-6:00 PM
393-396
(Ernest N. Morial Convention Center)
Moderators:
Bradley M. Haverkos, MD, MS, MPH, Ohio State University
and
Enrica Marchi, MD, PhD, University of Virginia
Disclosures:
Marchi: University of virginia: Patents & Royalties: 3062/170 PROV; Merck: Research Funding; Celgene/BMS: Research Funding; Astex Pharmaceuticals: Research Funding; Kyowa Kirin: Honoraria; Daiichi Sankyo: Other: Participation at advisory board; Kymera Therapeutics: Research Funding; Everest Clinical Research: Other: Data Safety Monitoring Commettee.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH